Press release 📈 Stocks 🌍 United States

Pathology Ventures Appoints Dominic Stockey as Executive Vice President

Pathology Ventures, LLC appoints former healthcare investment banker Dominic Stockey as EVP to lead industry partnerships and sponsor relations, effective immediately ahead of the CAP26 conference.

📅 September 29, 2026 🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: Pathology Ventures → 2/10 (65% confidence).

📊 Affected Assets (1)

Pathology Ventures

Neutral 🤖 65%

📅 Short-term 🌍 US · Explicit

Pathology Ventures announced the appointment of Dominic Stockey as EVP, a leadership change with limited direct market impact.

🎯 Key Takeaways

Dominic Stockey joins Pathology Ventures to spearhead strategic industry and sponsor partnerships.
The appointment follows Stockey's tenure as a healthcare investment banker.
Pathology Ventures represents a network of over 500 pathologists across the United States.

📝 Executive Summary

Pathology Ventures, LLC has named former healthcare investment banker Dominic Stockey as its new Executive Vice President. Stockey will oversee sponsor and industry partnerships for the physician-founded network, which represents over 500 pathologists nationwide.

❓ FAQ

What is the primary role of Dominic Stockey at Pathology Ventures?

Dominic Stockey serves as the Executive Vice President, responsible for leading sponsor and industry partnerships for the organization.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article